Podiatrist · Brooklyn, NY
NPI
1235226689
Since 2006
Specialty
Podiatrist
Code 213E00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
146 Sheridan Ave
Brooklyn, NY, 11208
Phone (718) 235-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,179 services
Medicare patients, 2024
178
Average age 72
Drug cost, 2024
$521K
1,238 prescriptions
Company payments, 2025
$125
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Afshin Ganjian was code 99213 (office e&m - established), 459 times for 136 patients. In total Afshin Ganjian billed 1,179 services in 21 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 459 | 136 | $79.57 | $37K |
| 11720 Nail Procedure | Office | 230 | 81 | $29.64 | $6,816 |
| G0127 Trimming of dystrophic nails, any number | Office | 191 | 65 | $10.94 | $2,090 |
| 11056 Removal or Shaving of Skin Growth | Office | 181 | 63 | $75.49 | $14K |
| 99203 Office E&M - New | Office | 31 | 31 | $100.40 | $3,112 |
By year: 2022 $80K for 1,312 services; 2023 $67K for 1,165 services; 2024 $67K for 1,179 services.
Medicare prescription drug claims, 2024
In 2024, the drug Afshin Ganjian prescribed most often to Medicare patients was Ciclopirox (Ciclopirox Olamine), with 313 prescriptions and refills. In total Afshin Ganjian wrote 1,238 Medicare prescriptions that cost $521K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ciclopirox Ciclopirox Olamine | 313 | 333 | 151 | $10K |
| Jublia Efinaconazole | 217 | 219 | 33 | $282K |
| Ketoconazole Generic | 146 | 150 | 54 | $3,398 |
| Ammonium Lactate Generic | 145 | 150 | 71 | $3,787 |
| Diclofenac Sodium Generic | 104 | 108 | 20 | $81K |
| Oxiconazole Nitrate Generic | 70 | 72 | Under 11 | $31K |
| Mupirocin Generic | 41 | 43 | 29 | $257 |
| Naftifine Hcl Generic | 24 | 24 | Under 11 | $19K |
| Ciclopirox Generic | 23 | 23 | Under 11 | $1,725 |
| Doxepin Hcl Generic | 22 | 22 | Under 11 | $5,239 |
| Tavaborole Generic | 18 | 20 | Under 11 | $2,097 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 14 | 14 | 14 | $133 |
| Naftin Naftifine Hcl | 13 | 15 | Under 11 | $6,838 |
| Clotrimazole Generic | 11 | 11 | Under 11 | $226 |
Brand drugs: 280 claims; generic drugs: 958 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Afshin Ganjian $125 ($125 in general payments such as food, travel and fees) from 1 company. The largest payer was Paratek Pharmaceuticals, Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.